T. Weber

A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells.

S. Theurich, A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, 2014, Cytotherapy.

In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy

W. Bloch, A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, 2015, Oncoimmunology.

Selective responses of mouse T lymphocytes to different T mitogens and in mixed lymphocyte culture induced cytolysis reaction.

A. Ranki, P. Roberts, P. Häyry, 1976, Cellular immunology.

CD40-activated B cells induce anti-tumor immunity in vivo

S. Theurich, A. Shimabukuro-Vornhagen, M. von Bergwelt-Baildon, 2016, Oncotarget.